Our MSC related services
- Isolation and expansion of autologous or allogeneic adult adipose-derived MSCs
- Expansion of autologous and allogeneic adult bone marrow MSCs
- Mesodermal Trilineage differentiation of MSCs (chondrocytes, osteocytes, myocytes)
- Purification of the secretome from co-cultured cells
- Exosome production and characterization
We provide all regulatory QC specified by the EMA or FDA, and all the required documentary support for the cells.
GMP facilities
Histocell owns a new Advanced Therapies GMP cell production unit with more than 600 m2 of capacity
- GMP manufacturing suites and associate infrastructure
- Fully equipped to manufacture autologous and allogenic therapies
- Pilot plant: new process setting up
- Currently designed to support pre-clinical and clinical phases
- Setting them to support commercial manufacturing
- Current cell therapy and large cell stocks (MCB, WCB)
- Production of cell-derived biological drugs as secretomes and exosomes
- Around 1200 batches/year